Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04520100 · ClinicalTrials.gov registry record · NA

Pilot Trial of Hypnosis and Enhanced Communication In Patients Undergoing MRI

A NA study of Anxiety and Magnetic Resonance Imaging, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04520100: Completed NA study of Anxiety and Magnetic Resonance Imaging, sponsored by University of Colorado, Denver.

NCT04520100 is a NA study of Anxiety and Magnetic Resonance Imaging that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04520100, a NA study of Anxiety and Magnetic Resonance Imaging, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this study is to enhance patient comfort during magnetic resonance (MR) exams by reducing anxiety and movement during the exam, thereby decreasing the time spent in magnetic resonance imaging (MRI) scanner and potentially improving patient satisfaction with the clinical care experience. This will be done with a trial focusing on studying the effects of clinical hypnosis and focused communication training on patient anxiety and other metrics during an MRI examination.

Primary Outcome

Patient will complete the STAI-AD Short forms. Higher scores are correlated with higher anxiety (a worse outcome) and lower scores are correlated with less anxiety. Maximum score is 80 and minimum score is 20.

Interventions

  • BEHAVIORAL Clinical Hypnosis performed by the PI
  • BEHAVIORAL Care by technician trained in empathic communication

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-10-02
Est. Completion 2022-01-23
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT04520100 record still lists

NCT04520100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower).

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Clinical Hypnosis performed by the PI is the first listed.

NCT04520100 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT04520100 about?

NCT04520100 is a clinical study titled "Pilot Trial of Hypnosis and Enhanced Communication In Patients Undergoing MRI". The overarching goal of this study is to enhance patient comfort during magnetic resonance (MR) exams by reducing anxiety and movement during the exam, thereby decreasing the time spent in magnetic resonance imaging (MRI) scanner and potentially improving patient satisfaction with the clinical care ...

What is the current status of trial NCT04520100?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-10-02. Estimated completion is 2022-01-23.

What conditions does trial NCT04520100 study?

This clinical trial studies the following conditions: Anxiety, Magnetic Resonance Imaging, Claustrophobia.

What interventions are being tested in trial NCT04520100?

The interventions under investigation include: Clinical Hypnosis performed by the PI (BEHAVIORAL), Care by technician trained in empathic communication (BEHAVIORAL).

Who is sponsoring clinical trial NCT04520100?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04520100 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04520100's enrollment target sits among peer trials

40 266th of 364 higher than 83 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04520100, the US trial registry maintained by the National Library of Medicine. NCT04520100 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.